NK-92: an ‘off-the-shelf therapeutic’ for adoptive natural killer cell-based cancer immunotherapy

Natural killer (NK) cells are increasingly considered as immunotherapeutic agents in particular in the fight against cancers. NK cell therapies are potentially broadly applicable and, different from their T cell counterparts, do not cause graft-versus-host disease. Efficacy and clinical in vitro or...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer Immunology, Immunotherapy Immunotherapy, 2016-04, Vol.65 (4), p.485-492
Hauptverfasser:	Suck, Garnet, Odendahl, Marcus, Nowakowska, Paulina, Seidl, Christian, Wels, Winfried S., Klingemann, Hans G., Tonn, Torsten
Format:	Artikel
Sprache:	eng
Schlagworte:	Antigens Blood & organ donations Cancer Cancer Research Cell Line, Tumor Cell Proliferation Cells Cells, Cultured Clinical Trials as Topic Cytotoxicity Cytotoxicity, Immunologic Epidermal growth factor Good Manufacturing Practice Graft versus host disease Humans Immunoglobulins Immunology Immunotherapy Immunotherapy, Adoptive - methods Killer Cells, Natural - immunology Killer Cells, Natural - transplantation Leukocytes Medicine Medicine & Public Health Neoplasms - immunology Neoplasms - therapy Oncology Symposium-in-Writing Paper Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!